How RadNet’s (RDNT) AI Reporting Tools Could Improve Imaging Center Scale and Workflow
DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite
Radnet's DeepHealth Unit Receives FDA 510(k) Clearances For Two New Breast Suite Functionalities
Why RadNet (RDNT) Stock Is Down Today
RadNet’s AI Reporting Pro And New Loan Put Focus On Valuation
RadNet Secures $250 Million Incremental Term Loan to Fund Strategic Growth Opportunities and Reduces the Interest Rates on its Credit Facility by 0.25%
Radnet Unit DeepHealth Launches Reporting Pro, An AI-Powered Tool For Generating Clinical Reports
RadNet (RDNT): Buy, Sell, or Hold Post Q1 Earnings?
Testing & Diagnostics Services Stocks Q1 Results: Benchmarking RadNet (NASDAQ:RDNT)
Is RadNet’s New US$200 Million Term Loan Reshaping the Investment Case for RDNT?
RadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth Opportunities
Alpha Wave Global Reduces RadNet Stake, According to Recent SEC Filing
Do Options Traders Know Something About RadNet Stock We Don't?
Barclays Lowers RadNet (RDNT) Price Target, Says Imaging Business Continues to Outperform
RadNet to Host Men's Health Webinar on June 13, 2026
Assessing RadNet (RDNT) Valuation After Recent Share Weakness And AI Imaging Growth Hopes
Barclays Maintains Overweight on RadNet, Lowers Price Target to $65
RDNT Q1 Deep Dive: Advanced Imaging, Digital Health and Acquisitions Drive Growth
The RadNet, Inc. (NASDAQ:RDNT) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Earnings To Watch: RadNet (RDNT) Reports Q1 Results Tomorrow
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.